Organ procurement - Strategies to optimize donor availability

Seminars in Respiratory and Critical Care Medicine

Volumn 22, Issue 5, 2001, Pages 541-550

  Williams, T J ^a   Snell, G I ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

Donor assessment; Donor management; Lung transplantation

Indexed keywords

ARTERIAL GAS; HUMAN; LUNG TRANSPLANTATION; ORGAN CULTURE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; THORAX RADIOGRAPHY; XENOGRAFT;

EID: 0035183952     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18426     Document Type: Review

References (43)

1. Organ donation: The "Spanish model."
2. International guidelines for the selection of lung transplant candidates
3. Brain death in three neurosurgical units
4. Heart transplantation on the first day of life from an anencephalic donor
5. Outcome of persistent vegetative state following hypoxic or traumatic brain injury in children and adolescents
6. Brief report: Late improvement in consciousness after post-traumatic vegetative state
7. The history of heart and lung transplantation
8. The effects of recombinant tissue-type plasminogen activator (rt-PA) on canine cadaver lung transplantation
9. Comparison of outcomes between living donor and cadaveric lung transplantation in children
10. Transgenic human decay accelerating factor makes normal pigs function as a concordant species
11. Porcine endogenous retrovirus (PERV) was not transmitted from transplanted porcine endothelial cells to baboons in vivo
12. The colony stimulating factor (CSF)
13. Presumed consent to organ donation: 10 years' experience in Belgium
14. Public attitudes and behavior regarding organ donation
15. Financial compensation for cadaver organ donation: Good idea or anathema
16. Donor criteria and evaluation
17. Donor procurement and management
18. Donor sepsis is not a contraindication to cadaveric organ donation
19. Successful transplantation of a lung allograft from a carbon monoxide-poisoning victim
20. Lung transplantation from dialysis dependent donors
21. Can hepatitis B core antibody positive livers be used safely for transplantation: Hepatitis B virus detection in the liver of individuals who are hepatitis B core antibody positive
22. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: Implications for policies on organ procurement
23. Hepatitis C virus infection and lung transplantation: A survey of practices
24. Creutzfeldt-Jakob disease, new variant Creutzfeldt-Jakob disease, and bovine spongiform encephalopathy
25. Susceptibility of lung transplants to preformed donorspecific HLA antibodies as detected by flow cytometry
26. Hyperacute rejection of a pulmonary allograft: Immediate clinical and pathologic findings
27. Hyperacute rejection following lung transplantation
28. The natural history of chronic airflow obstruction
29. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation
30. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs
31. Maximizing the utilization of donor organs offered for lung transplantation
32. Elevated levels of interleukin-8 in donor lungs is associated with early graft failure after lung transplantation
33. Transmission of Lactobacillus pneumonia by a transplanted lung
34. Early bacterial infections in lung transplant recipients
35. Influence of the donor lung on development of early infections in lung transplant recipients
36. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths
37. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation
38. Aetiology of asthma: Lessons from lung transplantation
39. Maximizing thoracic organ transplant opportunities: The importance of efficient coordination
40. Differences in early results after single-lung transplantation
41. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome